03.25.26 -- U.S. Pharma Tariffs And MFN: Manufacturing And Procurement Impact

Through Home Trial Support (HTS), it is possible to carry out even the most demanding sampling protocols safely, consistently, and at scale—bringing collection and processing directly to patients.

Beroe Inc.'s Mathini Ilancheran discusses the 2025 U.S. pharma tariff framework and translates it into actionable procurement and outsourcing responses.

Centralized PD trials cut variability, speed enrollment, and enable genetic stratification, delivering high‑quality data and faster progress from early‑phase research to late‑stage development.

Ovarian cancer remains one of the deadliest gynecologic malignancies. Successful clinical trials in this space demand deep therapeutic expertise, operational agility, and global coordination.

Are minor inconsistencies in room setup and technician technique quietly compromising your study data? Learn how closing small operational gaps can prevent major downstream risks.

This presentation explores the groundbreaking study that introduces Six-Minute Activity 95th Centile (6M95C), a novel accelerometry-based tool that provides a real-world view of functional capacity.

From optimizing first-in-human strategies to leveraging AI-enabled digital architectures, the integrated CDMO-CRO services model reduces risk and maximizes program value.

By utilizing consistent, repeatable system builds, sponsors gain significant advantages during protocol amendments and operational changes.

Our team in Japan provides comprehensive services including primary and secondary clinical packaging and labeling, comparator sourcing, cold chain storage, and local and global distribution.

Accelerate your therapy's path to market and create better experiences with the right partner to provide end-to-end Clinical Development expertise.

Strategic planning, data-driven decisions, and global coordination accelerate clinical timelines while ensuring quality. Explore risk-based monitoring and practical ways to overcome complexity.

Simplifying label requests, integrating translation and regulatory support, and using paperless workflows can reduce turnaround times while maintaining high-quality label content.